483 King Pharmaceuticals. Jun 2012

483 King Pharmaceuticals. Jun 2012

Rebecca Dombrowski FDA, Emily Orban FDA$119.00 - Available Now

FDA investigators audited the King Pharmaceuticals. - Rochester, MI, United States facility and issued inspectional observations (via FDA 483) on 15 Jun 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 15 Jun 2012
  • Location: Rochester, United States
  • FEI: 1876582
Add To Cart